Special Issue "New Drug Delivery System"
Deadline for manuscript submissions: closed (1 March 2018)
Prof. Dr. Rita Muzzalupo
Department Pharmacy, Health and Nutrition Sciences, University of Calabria, 87036 Arcavacata di Rende (CS)-Italy
Website | E-Mail
Interests: Vesicular systems and polymeric carrier for drug delivery; Nanotechnologies for Drug targeting; Nanotechnologies for Transdermal delivery; Nanotechnologies for Cancer therapy
Dr. Lorena Tavano
Drug delivery is the method or process of administering a pharmaceutical compound to achieve a therapeutic effect in humans or animals. Delivering drugs at controlled rate, slow delivery, targeted delivery are other very attractive methods and have been pursued enthusiastically.
Various drug delivery and targeting systems have been developed in order to minimize drug degradation and adverse effect, and to increase drug bioavailability. Site-specific drug delivery may be either an active and/or passive process.
In the last few years, researchers have appreciated the potential benefits of nanotechnologies in providing vast improvements to drug delivery and targeting. Improving delivery techniques that minimize toxicity and increase efficacy offer great potential benefits to patients, and open up new markets for pharmaceutical companies.
As Guest Editor, I invite researchers to submit their relevant studies on this topic to Special Issue of Molecules. The aim of this issue is to provide a recent insight into the new nanotechnologies useful for drug delivery.Prof. Dr. Rita Muzzalupo
Dr. Lorena Tavano
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All papers will be peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Molecules is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1800 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- Nanoparticle in drug delivery
- Liposome in drug delivery
- Niosome in drug delivery
- Polymeric carrier in drug delivery
- Nanotechnologies for Drug targeting
- Nanotechnologies for Gene therapy
- Nanotechnologies for Transdermal delivery
- Nanotechnologies for Cancer therapy
- Theranostic nanoparticles
- Magnetic nanoparticles